Jiye Liu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Annamaria Gulla, Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet Kemal Samur, Cirino Botta, Selma Cifric, Pietro Folino, Delaney Vinaixa, Francesca Barello, Cole Clericuzio, Vanessa Katia Favasuli, Domenico Maisano, Srikanth Talluri, Rao Prabhala, Giada Bianchi, Mariateresa Fulciniti, Kenneth Wen, Keiji Kurata, Jiye Liu, Johany Penailillo, Alberto Bragoni, Anna Sapino, Paul G Richardson, Dharminder Chauhan, Ruben D Carrasco, Teru Hideshima, Nikhil C Munshi, Kenneth C Anderson
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma. Blood 143 (25) (2024)
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, Su Wang, Daisuke Ogiya, Tian-Yu Song, Keiji Kurata, Johany Penailillo, Eugenio Morelli, Tingjian Wang, Xiaoning Hong, Annamaria Gulla, Yu-Tzu Tai, Nikhil C Munshi, Paul Richardson, Ruben Carrasco, Teru Hideshima, Kenneth C Anderson
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma. Nature communications 15 (1) (2024)
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, Su Wang, Daisuke Ogiya, Tian-Yu Song, Keiji Kurata, Johany Penailillo, Eugenio Morelli, Tingjian Wang, Xiaoning Hong, Annamaria Gulla, Yu-Tzu Tai, Nikhil C Munshi, Paul Richardson, Ruben Carrasco, Teru Hideshima, Kenneth C Anderson
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma. Nature communications 15 (1) (2024)
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, Su Wang, Daisuke Ogiya, Tian-Yu Song, Keiji Kurata, Johany Penailillo, Eugenio Morelli, Tingjian Wang, Xiaoning Hong, Annamaria Gulla, Yu-Tzu Tai, Nikhil C Munshi, Paul Richardson, Ruben Carrasco, Teru Hideshima, Kenneth C Anderson
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma. Nature communications 15 (1) (2024)
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, Su Wang, Daisuke Ogiya, Tian-Yu Song, Keiji Kurata, Johany Penailillo, Eugenio Morelli, Tingjian Wang, Xiaoning Hong, Annamaria Gulla, Yu-Tzu Tai, Nikhil C Munshi, Paul Richardson, Ruben Carrasco, Teru Hideshima, Kenneth C Anderson
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma. Nature communications 15 (1) (2024)
Lijie Xing, Yuntong Liu, Jiye Liu
Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy. Cancers 15 (8) (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Keiji Kurata, Mehmet Kemal Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gulla, Yu-Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C Anderson
BRD9 degradation disrupts ribosome biogenesis in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Lijie Xing, Yuntong Liu, Jiye Liu
Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy. Cancers 15 (8) (2023)
Debasmita Dutta, Jiye Liu, Kenneth Wen, Keiji Kurata, Maria Teresa Fulciniti, Annamaria Gulla, Teru Hideshima, Kenneth C Anderson
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma. Blood cancer journal 13 (1) (2023)
Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Kemal Samur, Tomasz Sewastianik, Daisuke Ogiya, Gang An, Shaobing Gao, Li Yang, Tong Ji, Giada Bianchi, Kenneth Wen, Yu-Tzu Tai, Nikhil Munshi, Paul Gerard Richardson, Ruben Carrasco, Yong Cang, Kenneth C Anderson
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Science advances 7 (23) (2021)
Lijie Xing, Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen, Yuyin Li, Liang Lin, Phillip A Hsieh, Shih-Feng Cho, Gang An, Lugui Qiu, Krista Kinneer, Nikhil Munshi, Kenneth C Anderson, Yu-Tzu Tai
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)